COVID-19 Miniseries Episode 10: How to Mitigate Drug-Induced Sudden Cardiac Death From Hydroxychloroquine
Published April 3, 2020
51 min
    Add to queue
    Copy URL
    Show notes
    This episode was recorded on April 3, 2020Claim credit here:  Michael J. Ackerman, M.D., Ph.D. (@MJAckermanMDPhD)Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)The administration of hydroxychloroquine and azithromycin, along with other very common medications could result in drug-induced sudden cardiac death caused by drug-induced QT prolongation, in some patients. In order to avoid the wrong medication, for the wrong patient, at the wrong time, Dr. Michael Ackerman shares how to assess your patient’s risk, how to find and measure their QTc value, and neutralize the threat.Deeper Dive:Link to Journal Pre-Proof: to COVID-19 QTc Calculator and other resources: JR, Noseworthy PA, Friedman PA, Ackerman MJ. Urgent guidance for navigating and circumventing the QTc prolonging and torsadogenic potential of possible pharmacotherapies for COVID-19 [published online ahead of print March 25, 2020]. Mayo Clin Proc. Emergency Use Authorization (EUA) of hydroxychloroquine sulfate: Clinic Connected Care - Genetic Heart Rhythm Diseases with the Mayo Clinic’s School of Continuous Professional Development online at or on Twitter @MayoMedEd.
        0:00:00 / 0:00:00